Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
single-center, randomized, double-blind, placebo-controlled Phase 2 study to evaluate safety and efficacy of overnight metyrapone in patients with MACS.
Epistemonikos ID: 118bcaf46031215dfde3b0dc1b2acd2722a1f406
First added on: Aug 23, 2025